Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma.

Chauhan, Ashutosh; Semwal, Deepak Kumar; Mishra, Satyendra Prasad; Goyal, Sandeep; Marathe, Rajendra; Semwal, Ruchi Badoni

Chauhan, Ashutosh; Semwal, Deepak Kumar; Mishra, Satyendra Prasad; Goyal, Sandeep; Marathe, Rajendra; Semwal, Ruchi Badoni.

Afiliación

Chauhan A; Department of Urology, Postgraduate Institute of Medical Education & Research, Chandigarh 160012, India. ashutosh_biotech2006@yahoo.com.
Semwal DK; Department of Biotechnology, Faculty of Biomedical Sciences, Uttarakhand Ayurved University, Harrawala, Dehradun 248001, Uttarakhand, India. ashutosh_biotech2006@yahoo.com.
Mishra SP; Department of Phytochemistry, Faculty of Biomedical Sciences, Uttarakhand Ayurved University, Harrawala, Dehradun 248001, Uttarakhand, India. dr_dks.1983@yahoo.co.in.
Goyal S; Vice Chancellor, Uttarakhand Ayurved University, Harrawala, Dehradun 248001, Uttarakhand, India. vc@uau.ac.in.
Marathe R; Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh 160012, India. sandeepgoyalpgi@gmail.com.
Semwal RB; Department of Pediatrics, Postgraduate Institute of Medical Education & Research, Chandigarh 160012, India. rajendra.bt09@gmail.com.

Med Sci (Basel) ; 4(4)2016 Oct 17.

Article en En | MEDLINE | ID: mdl-29083380

Palabras clave

mammalian target of rapamycin; mitogen activated protein kinase; renal cell carcinoma; target therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Med Sci (Basel) Año: 2016 Tipo del documento: Article País de afiliación: India Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google